Veradigm - MDRX Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veradigm in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MDRX shares.
View MDRX analyst ratings or view top-rated stocks.

7 equities research analysts have issued 12-month target prices for Veradigm's shares. Their MDRX share price forecasts range from $17.00 to $26.00. On average, they expect the company's stock price to reach $22.67 in the next twelve months. This suggests a possible upside of 26.8% from the stock's current price.
View analysts price targets for MDRX or view top-rated stocks among Wall Street analysts.

Veradigm's stock was trading at $17.64 at the beginning of 2023. Since then, MDRX shares have increased by 1.3% and is now trading at $17.87.
View the best growth stocks for 2023 here.

Veradigm saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 10,740,000 shares, an increase of 21.6% from the December 31st total of 8,830,000 shares. Based on an average trading volume of 1,300,000 shares, the short-interest ratio is currently 8.3 days. Currently, 10.1% of the company's shares are sold short.
View Veradigm's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our MDRX earnings forecast.

Veradigm will be holding an earnings conference call on Thursday, February 23rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Veradigm Inc. (NASDAQ:MDRX) posted its quarterly earnings results on Thursday, November, 3rd. The software maker reported $0.20 EPS for the quarter, beating analysts' consensus estimates of $0.15 by $0.05. The software maker had revenue of $151.90 million for the quarter, compared to analyst estimates of $152.79 million. Veradigm had a trailing twelve-month return on equity of 10.74% and a net margin of 7.25%. The business's quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.21 EPS.

Veradigm announced that its board has approved a share repurchase program on Wednesday, May 26th 2021, which authorizes the company to buyback $350,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 14% of its shares through open market purchases. Shares buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Veradigm updated its FY 2023 earnings guidance on Wednesday, January, 11th. The company provided EPS guidance of $0.90-$1.00 for the period, compared to the consensus EPS estimate of $0.95. The company issued revenue guidance of $640.00 million-$660.00 million, compared to the consensus revenue estimate of $656.84 million.

796 employees have rated Veradigm Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Veradigm investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

Veradigm trades on the NASDAQ under the ticker symbol "MDRX."

Veradigm's stock is owned by a number of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (0.55%), Allspring Global Investments Holdings LLC (0.26%), Comerica Bank (0.08%), State of Alaska Department of Revenue (0.07%), Yousif Capital Management LLC (0.07%) and SummerHaven Investment Management LLC (0.05%). Insiders that own company stock include Brian Farley, David B Stevens, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton, Tejal Vakharia and Thomas Langan.
View institutional ownership trends.

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MDRX stock can currently be purchased for approximately $17.87.

Veradigm (NASDAQ:MDRX) has a market capitalization of $1.95 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.

The company employs 8,000 workers across the globe.

Veradigm's mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for the company is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.